Drugs / Mbiotix
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05204641 Comparator | Jan 2022 → Oct 2024 | Parkinson disease | Medical University of Warsaw | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mbiotix | “The patients were randomly assigned to receive either fecal microbiota (Mbiotix, Human Biome Institute) or placebo (auto-fecal microbiota, prepared from the patient's stool) in...” PMID 41674471 ↗ Feb 2026 |
| Route | Other | “It will be administered to intestine during colonoscopy.” NCT05204641 ↗ |